Dasatinib boosts γδ T cell expansion and memory phenotypes with enhanced antitumor immunity

Abstract Γδ T cells offer unique advantages in cancer immunotherapy because of their MHC-independent recognition of tumor antigens and innate cytotoxic potential. However, conventional ex vivo expansion protocols using zoledronic acid (Zol) and IL-2 often lead to terminal differentiation and diminis...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Jeng-Rong Lin, Ying‐Chyi Song, Yu‐Lun Chou, Yun-Jhen Chen, Chi Hsiao, Ju-Pi Li, Ying-Jui Ho, Wen-Chieh Liao, Hung-Rong Yen, Chiung-Hui Liu
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Springer 2026-03-01
Saila:	Cancer Immunology, Immunotherapy
Gaiak:	γδ T cells Dasatinib Drug screening Ex vivo expansion Glioblastoma Triple-negative breast cancer
Sarrera elektronikoa:	https://doi.org/10.1007/s00262-026-04335-w
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!